Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name ZEB1-AS1
   Synonyms NR_024284
   Region GRCh38_10:31206278-31320447    Sequence
   Ensembl ENSG00000237036
   RefSeq NR_024284
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name prostate cancer
   ICD-0-3 C61.9  
   Methods Western blot, Luciferase reporter, RIP
   Sample cell lines (PC3, DU145, NCI-H1299, A549, T98G, U251, A375, A875, HUVEC, HBE, SK-MES-1, HeLa, 293, LO2).
   Expression Pattern up-regulated
   Function Description

Collectively, ZEB1-AS1 functions as an oncogene in prostate cancer via epigenetically activating ZEB1 and indirectly regulating downstream molecules of ZEB1. Also, BMI1 promotes cell survival and attenuated chemosensitivity to docetaxelin prostate cancer. Work in mammalian H3K4 methylation has primarily focused on MLL1, the function of which depends on the participation of the helper proteins WDR5, RBBP5 and ASH2L. The discrepancies above might be explained by different cell lines used in different studies or different splicing variants of ZEB1-AS1.A construct with site-directed mutation of the corresponding seed sequence GTCATAT was prepared by overlapping PCR and designated as pGL3-BMI1-MUT. Dual reporter gene assay was performed as described.

   Pubmed ID 28830551
   Year 2017
   Title Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer.
   External Links
   Links for  ZEB1-AS1 GenBank       HGNC       lncrnadb       Noncode
   Links for  prostate cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.